当前位置: 首页 > 期刊 > 《中国实用医药》 > 2016年第8期
编号:12753372
急性冠脉综合征患者与sCAM关系分析(2)
http://www.100md.com 2016年3月15日 中国实用医药 2016年第8期
     [4]Haim M, Tanne D, Boyko V, et al. Soluble intercellular adhesion molccule-1 and long-term risk of acute coronary events in patients with chronic coronary heart disease. Data from the Bezafibrate Infarction Prevention (BIP) Study. J Am Coll Cardiol, 2002, 39(7):1133-1138.

    [5]Wetzel A, Chavakis T, Preissner KT, et al. Human Thy-1(CD90) on activated endothelial cells is a counterreceptor for the leukocyte integrin Mac-1(CD11b/CD18). J Immunol, 2004, 172(6):3850-3859.

    [6]刘艳英, 刘永铭, 杨京港.高脂血症患者补体调节蛋白CD55、CD59表达与脂肪细胞因子的关系研究.中国老年学杂志, 2009, 29(13):1622-1624.

    [7]Peng DQ, Zhao SP, Li YF, et al. Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndrome. Clin Chim Acta, 2002, 319(1):19-26.

    [8]Dgawa H, Sakamoto T, Nishiyamn K, et al. Elevated levels of soluble intercellular adhesion molecule-1 in the coronary circulation of patients with coronary organic stenosis and spasm. Jpn Cire J, 2000, 64(3):170-176.

    [9]Parker C 3rd, Vita JA, Freedman JE, et al. Soluble adhesion molecules and unstable coronary artery disease. Atherosclerosis, 2001, 156(2):417-424.

    [收稿日期:2015-07-10], 百拇医药(吴素铭?张立春?张馨)
上一页1 2